Palomid 529

DB12812InvestigationalSmall molecule

Palomid 529 has been used in trials studying the treatment of Age-Related Macular Degeneration.

Chemical structure of Palomid 529
Mechanism
Curator reviewed
Formula / weight
C24H22O6 · 406.434 g/mol (avg)
Also known as
6H-DIBENZO(B,D)PYRAN-6-ONE, 8-(1-HYDROXYETHYL)-2-METHOXY-3-((4-METHOXYPHENYL)METHOXY)- · 8-(1-HYDROXY-ETHYL)-2-METHOXY-3-(4-METHOXY-BENZYLOXY)-BENZO(C)CHROMEN-6-ONE · PALOMID-529
Code names
P-529 · SG-00529

Resolves to

Compound
UNIIXV9409EWG4CAS914913-88-5ChEMBLCHEMBL2141712PubChem11998575
Structure
InChIKeyYEAHTLOYHVWAKW-UHFFFAOYSA-NSMILESCOC1=CC=C(COC2=C(OC)C=C3C(OC(=O)C4=CC(=CC=C34)C(C)O)=C2)C=C1
Targets
P42345MTORQ9BPZ7MAPKAP1

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Palomid 529, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In